The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-0604
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Turova E.L.

Sverdlovsk Regional Clinical Hospital No. 1

Relationship of patients with multiple sclerosis to vaccination against COVID-19

Authors:

Turova E.L.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7‑2): 29‑33

DOI: 10.17116/jnevro202312307229

Read: 1888 times

Download PDF (RU)
Contact the author
Table of contents

RELATIONSHIP OF PATIENTS WITH MULTIPLE SCLEROSIS TO VACCINATION AGAINST COVID-19
RELATIONSHIP OF PATIENTS WITH MULTIPLE SCLEROSIS TO VACCINATION AGAINST COVID-19

To cite this article:

Turova EL. Relationship of patients with multiple sclerosis to vaccination against COVID-19. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(7‑2):29‑33. (In Russ.)
https://doi.org/10.17116/jnevro202312307229

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
 
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
ALDH1, CD133, CD34-positive cancer stem cells in lung adenocarcinoma in patients who had a new coro­navirus infe­ction and retained the persistence of viral proteins in the lung tissue. Russian Journal of Archive of Pathology. 2024;(5):5-14
Factors affe­cting the quality of life of patients with neurological mani­festations of post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(9):44-50
«Cytokine storm» as an immu­nopathologic reaction in pregnant women in the first trimester. Russian Bulletin of Obstetrician-Gynecologist. 2024;(5):19-24
Inci­dence of sudden cardiac death among diseases of the circulatory system during the COVID-19 pandemic in the Penza region. Fore­nsic Medi­cal Expe­rtise. 2024;(5):10-14
Morphofunctional and biochemical dete­rminants of endo­thelial function in patients with a new coro­navirus infe­ction COVID-19. Russian Journal of Preventive Medi­cine. 2024;(10):90-96
Low-level laser therapy in multiple scle­rosis: justification and opti­mization methods of application. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):45-56
Glial fibrillary acidic protein: is there a rela­tionship with the course of multiple scle­rosis and traumatic brain injury before the onset of multiple scle­rosis?. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):80-84
An indi­vidual approach to the diagnosis and treatment of an acute psychotic condition in a patient with a multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):97-102
Loca­lization features of FAP-positive acti­vated stro­mal cells in fibrosis in patients with new coro­navirus infe­ction COVID-19. Russian Journal of Archive of Pathology. 2024;(6):5-14
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
Abstract:

OBJECTIVE

To study the attitude of patients with multiple sclerosis (MS) to vaccination as a method of preventing infectious diseases, in particular, COVID-19.

MATERIAL AND METHODS

The data of a survey of 408 patients with MS in the Sverdlovsk region in relation to vaccination against COVID-19, conducted using the original questionnaire, were analyzed.

RESULTS

According to the survey data, 266 (65.2%) patients with MS are positive about vaccination. 222 (54.4%) patients with MS refused vaccination. The most common reasons for refusal were — fear that the vaccine could worsen the state of health — 44.1%, coronavirus infection in the last 6 months — 14.85%, «I was always told that I should not be vaccinated» — 14.4%, a combination of the above answers — 16.65%. The accumulated world experience and our observations demonstrate the important role of vaccination of patients with MS from COVID-19.

CONCLUSIONS

It is necessary to rise the awareness of vaccination among patients with MS, since until recently this has been given insufficient attention.

Keywords:

multiple sclerosis
vaccination
COVID-19
adherence

Authors:

Turova E.L.

Sverdlovsk Regional Clinical Hospital No. 1

Received:

31.01.2023

Accepted:

10.03.2023

Close metadata

References:

  1. Bsteh G, Bitschnau C. Multiple sclerosis and COVID‐19: how many are at risk? Eur J Neurol. 2021;54(10):3369-3374. https://doi.org/10.1111/ene.14555
  2. Khachanova NV, Davydovskaya MV, Totolyan NA, et al. Recommendations for vaccination of patients with multiple sclerosis from COVID-19, March 29, 2021. Link is active on 01/15/2023. (In Russ.). https://www.mapcms.ru/upload/iblock/fc9/fc99cc823233b5256af4293617b61870.pdf
  3. Landtblom AM. Multiple sclerosis and COVID‐19: The Swedish experience. Acta Neurol Scand. 2021;144(3):229-235.  https://doi.org/10.1111/ane.13453
  4. Salter A. Outcomes and Risk Factors Associated With SARS-CoV-2 Infection in a North American Registry of Patients with Multiple Sclerosis. JAMA Neurol. 2021;78(6):699-708. 
  5. Simpson-Yap S. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. Neurology. 2021;97(11):1870-e1885. https://doi.org/10.1212/WNL.0000000000012753
  6. Simpson-Yap S. Updated results of the COVID-19 in MS global data sharing initiative validate consistent associations of anti-CD20 and other reported risk factors with severe COVID-19 outcomes. ECTRIMS 2021. Abstract 098. 
  7. Sormani MP. Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis. Ann Neurol. 2021;89(4):780-789.  https://doi.org/10.1002/ana.26028
  8. Sormani MP. Lessons learned from COVID-19 & MS registries and data gaps. Oral. Hot Topic 2: COVID-19 and MS. ECTRIMS 2021, 13 October.
  9. Landi D, Cola G. Safety of natalizumab reinfusion during active Sars-Cov-2 infection in patients with multiple sclerosis. Mult Scler Rel Dis. 2022;57(6):103345. https://doi.org/10.1016/j.msard.2021.103345
  10. EpiVacCorona. Vaccine based on peptide antigens for the prevention of COVID-19. Instructions for the use of LP-006504 dated 11.04.2022. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=34ca6cb0-7450-4f53-8bec-17d2bdf92c2b
  11. KoviVac (Coronavirus vaccine inactivated whole-virion concentrated purified). Instructions for the use of LP — 006800 dated February 19, 2021. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=956ad8ef-fb1c-4652-bec5-137afe7169fa
  12. Sputnik Light Vector vaccine for the prevention of coronavirus infection caused by the SARS-CoV-2 virus Instructions for use LP-006993 dated 5.06.2021. https://grls.rosminzdrav.ru/Grls_View_v2.aspx?routingGuid=1beeee94-94ed-4032-80fb-1ab2cfd00084
  13. Boyko AN, Sivertseva SA, Chemakina DS, et al. Vaccination and multiple sclerosis at the present stage. Journal of Neurology and Psychiatry. S.S. Korsakov. 2021;121(7/2):44-48. (In Russ.). https://doi.org/10.17116/jnevro202112107244
  14. Kasatkin DS, Korobko DS, Matson MD, et al. Vaccination in multiple sclerosis. Journal of Neurology and Psychiatry. S.S. Korsakov. 2022;122(9):29-36. (In Russ.). https://doi.org/10.17116/jnevro202212209129
  15. Farez M, Correale J. Practice guideline update summary: Vaccine preventable infections and immunization in multiple sclerosis. Neurology. 2019;93(8):584-594.  https://doi.org/10.1212/wnl.0000000000008157
  16. Shokouhi S, Hakamifard A. COVID-19 vaccine and corticosteroids: a challenging issue. Eur J Infl. 2021;19:20587392211066188. https://doi.org/10.1177/20587392211066188
  17. Sormani MP. Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies. EBioMedicine. 2021;72:103581. https://doi.org/10.1016/j.ebiom.2021.103581
  18. Capuano R. Humoral response to SARS-CoV-2 mRNA vaccine in patients with multiple sclerosis treated with natalizumab. Ther Adv Neurol Disord. 2021;14(7):1-3.  https://doi.org/10.1177/17562864211038111
  19. Tallantyre EC. Covid‐19 vaccine response in people with multiple sclerosis. Ann Neurol. 2022;9(1):89-100.  https://doi.org/10.1002/ana.26251
  20. Boekel L, Stalman E. OP0178 COVID-19 Breakthrough infections in vaccinated patients with immune-mediated inflammatory diseases and controls — data from two prospective cohort studies. Ann Rheum Dis. 2022;67(8):118-118. 
  21. Ehde DM, Roberts MK. Willingness to obtain COVID-19 vaccination in adults with multiple sclerosis in the United States. Mult Scler Rel Dis. 2021;49(8):102788. https://doi.org/10.1016/j.msard.2021.102788
  22. Serrazina F. Willingness to be vaccinated against COVID-19: an exploratory online survey in a Portuguese cohort of multiple sclerosis patients. Mult Scler Rel Dis. 2021;51:102880. https://doi.org/10.1016/j.msard.2021.102880
  23. Huang Y, Rodgers WJ. Willingness to receive a COVID-19 vaccine in people with multiple sclerosis-UK MS Register survey. Mult Scler Rel Dis. 2021;55(7):103175. https://doi.org/10.1016/j.msard.2021.103175
  24. Uhr L, Mateen F. COVID-19 vaccine hesitancy in multiple sclerosis: A cross-sectional survey. Mult Scler J. 2021;2(1):13524585211030647. https://doi.org/10.1177/13524585211030647
  25. Xiang XM. COVID-19 vaccination willingness among people with multiple sclerosis. Mult Scler J. 2021;2(7):20552173211017159. https://doi.org/10.1177/20552173211017159
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.